At the archive date, HENRY SCHEIN INC was expected to release its Q3 2026 10-Q filing on November 2, 2026, before market open. Last quarter: Henry Schein achieved a 6.7% revenue increase and 17.1% diluted EPS growth in Q2 FY2026, supported by internal demand across all segments and improved gross margin.
EPS Estimate
$1.38
Revenue Estimate
$3.54B
Analyst consensus captured from Finnhub and Financial Modeling Prep. This archived preview is no longer updated with later results; see the HSIC page for retained reports.
Drawn from management commentary in the Q2 2026 10-Q:
Internal constant currency sales grew 4.6%, with dental merchandise up 5.9%, dental equipment 2.2%, medical 3.9%, specialty products 3.2%, and technology up 9.1%—the highest internal growth rate among segments.
Gross margin improvement to 31.8% was attributed to favorable business mix and early benefits from value creation initiatives, particularly in the distribution segment.
The company recorded $29 million in restructuring charges, primarily for severance and facility exits, as part of a multi-year plan to integrate acquisitions and right-size operations.
Revenue
$3.46B
+6.73% YoY
EPS (Diluted)
$0.82
+17.14% YoY
Gross Margin
31.8%
+0.5 pts YoY
Operating Income
$171M
+13.25% YoY
Add HSIC to your watchlist to keep its archived reports easy to find. New filing alerts are no longer sent.